Hepatocellular carcinoma and liver cirrhosis: Assessment of the liver function after yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy

Digestive Diseases

Volumn 27, Issue 2, 2009, Pages 189-199

  Rühl, Ricarda ^a   Seidensticker, Max ^a   Peters, Nils ^a   Mohnike, Konrad ^a   Bornschein, Jan ^a   Schütte, Kerstin ^a   Amthauer, Holger ^a   Malfertheiner, Peter ^a   Pech, Maciej ^a   Ricke, Jens ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Hepatocellular carcinoma; High dose rate brachytherapy; Radiation induced liver disease; Yttrium 90 radioembolization

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; MICROSPHERE; RESIN; SORAFENIB; YTTRIUM 90;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IRRADIATION; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER INJURY; MALE; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; TREATMENT DURATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALBUMINS; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BRACHYTHERAPY; CARCINOMA, HEPATOCELLULAR; CHOLINESTERASES; EMBOLIZATION, THERAPEUTIC; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; YTTRIUM RADIOISOTOPES;

EID: 67650941469     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218352     Document Type: Article

References (21)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Bosch FX, Ribes J, Diaz M, Cleries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127(suppl 1): S5-S16.
3. Kulik LM, Atassi B, van Holsbeeck L, Sou- man T, Lewandowski RJ, Mulcahy MF, et al: Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 2006; 94:572-586.
4. Lu DS, Yu NC, Raman SS, Limanond P, Lass- man C, Murray K, et al: Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 2005; 234:954-960.
5. Ruhl R, Ricke J: Image-guided microtherapy for tumor ablation: from thermal coagulation to advanced irradiation techniques. Onkologie 2006; 29: 219-224.
6. Dick EA, Taylor-Robinson SD, Thomas HC, Gedroyc WM: Ablative therapy for liver tumours. Gut 2002; 50:733-739.
7. Galandi D, Antes G: Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. Cochrane Database Syst Rev 2004:CD003046.
8. Curley SA, Izzo F: Radiofrequency ablation of primary and metastatic hepatic malignancies. Int J Clin Oncol 2002; 7: 72-81.
9. Pech M, Werk M, Beck A, Stohlmann A, Ricke J: System continuity and energy distribution in laser-induced thermo therapy (in German). Rofo 2002;174:754-760.
10. Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M, et al: CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 2004; 58:1496-1505.
11. Ricke J, Wust P, Wieners G, Beck A, Cho CH, Seidensticker M, et al: Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 2004; 15:1279-1286.
12. 90Y microspheres (TheraSphere®): safety, tumor response, and survival. J Vasc Interv Radiol 2005; 16:1627-1639.
13. Geschwind JF, Salem R, Carr BI, Soulen MC, Thurston KG, Goin KA, et al: Yttrium-90 microspheres for the treatment of hepatocel- lular carcinoma. Gastroenterology 2004; 127(suppl 1):S194-S205.
14. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF: Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995; 31: 1237-1248.
15. Sangro B, Gil-Alzugaray B, Rodriguez J, Sola I, Martinez-Cuesta A, Viudez A, et al: Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer 2008;112:1538-1546.
16. El Serag HB, Marrero JA, Rudolph L, Reddy KR: Diagnosis and treatment of hepatocel- lular carcinoma. Gastroenterology 2008; 134:1752-1763.
17. Covey AM, Brody LA, Maluccio MA, Ge- trajdman GI, Brown KT: Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 2002; 224:542-547.
18. Salem R, Thurston KG: Radioembolization with yttrium-90 microspheres: a state-of- the-art BT treatment for primary and secondary liver malignancies. Part 1. Technical and methodologic considerations. J Vasc In- terv Radiol 2006;17:1251-1278.
19. 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2006; 66: 792-800.
20. Lau WY, Ho S, Leung TW, Chan M, Ho R, Johnson PJ, et al: Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of yt- trium-90 microspheres. Int J Radiat Oncol Biol Phys 1998; 40:583-592.
21. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, et al: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004;15:460-466.